PRIVATE cancer doctors are warning chemotherapy services in up to 35 regions are "at risk" if a dispute between the federal government and pharmacists over drug dispensing costs is not resolved by the weekend.
Private hospitals and the government appear unlikely to reach an agreement by December 1 over the fallout from the decision to cut the price paid under the Pharmaceutical Benefits Scheme for Docetaxel, a chemotherapy drug, by more than 70 per cent.
No comments:
Post a Comment